Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingpi Yanger granule cohort study in children with diarrhea
ChiCTR2000028911Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xingpi Yanger granule in diarrhea and infantile diarrhea (2 cohorts), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Cure rate and Antidiarrheal time. Started Jan 2020; status: recruiting.
02
Drugs
Xingpi Yanger granule
03
Conditions
diarrheainfantile diarrhea
Beyond the preview
Go deeper on ChiCTR2000028911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028911.